Description
4-Hydroxythiobenzamide, a compound utilized in the biomedical sector due to its probable anti-neoplastic attributes, exhibits auspicious outcomes in impeding neoplasm expansion through precise pathway targeting within malignant cells. Ongoing research delves into its efficacy across diverse cancer categories.